169 related articles for article (PubMed ID: 11008132)
41. Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein.
Enright EF; Govindarajan K; Darrer R; MacSharry J; Joyce SA; Gahan CGM
Mol Pharm; 2018 Dec; 15(12):5711-5727. PubMed ID: 30388019
[TBL] [Abstract][Full Text] [Related]
42. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers.
Taipalensuu J; Törnblom H; Lindberg G; Einarsson C; Sjöqvist F; Melhus H; Garberg P; Sjöström B; Lundgren B; Artursson P
J Pharmacol Exp Ther; 2001 Oct; 299(1):164-70. PubMed ID: 11561076
[TBL] [Abstract][Full Text] [Related]
43. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
44. The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model.
Derakhshandeh K; Hosseinalizadeh A; Nikmohammadi M
Arch Pharm Res; 2011 Nov; 34(11):1989-97. PubMed ID: 22139699
[TBL] [Abstract][Full Text] [Related]
45. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
46. Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.
Kesisoglou F; Zhou SY; Niemiec S; Lee JW; Zimmermann EM; Fleisher D
Pharm Res; 2005 Aug; 22(8):1320-30. PubMed ID: 16078142
[TBL] [Abstract][Full Text] [Related]
47. Transport and uptake effects of marine complex lipid liposomes in small intestinal epithelial cell models.
Du L; Yang YH; Xu J; Wang YM; Xue CH; Kurihara H; Takahashi K
Food Funct; 2016 Apr; 7(4):1904-14. PubMed ID: 27001385
[TBL] [Abstract][Full Text] [Related]
48. Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.
Juang V; Lee HP; Lin AM; Lo YL
Int J Nanomedicine; 2016; 11():6047-6064. PubMed ID: 27895479
[TBL] [Abstract][Full Text] [Related]
49. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
Li H; Song JH; Park JS; Han K
Int J Pharm; 2003 Jun; 258(1-2):11-9. PubMed ID: 12753749
[TBL] [Abstract][Full Text] [Related]
50. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
Ming X; Knight BM; Thakker DR
Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
[TBL] [Abstract][Full Text] [Related]
51. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
[TBL] [Abstract][Full Text] [Related]
52. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ
Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075
[TBL] [Abstract][Full Text] [Related]
53. Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium.
Xia D; He Y; Li Q; Hu C; Huang W; Zhang Y; Wan F; Wang C; Gan Y
J Control Release; 2018 Jan; 269():159-170. PubMed ID: 29129657
[TBL] [Abstract][Full Text] [Related]
54. [Mechanisms of action of transportation of liposomes and chitosan-coated liposomes containing leuprolide across intestine and Caco-2 cell].
Guo JX; Ping QN; Dong J; Li ZR; Li CJ
Yao Xue Xue Bao; 2005 Jan; 40(1):65-70. PubMed ID: 15881330
[TBL] [Abstract][Full Text] [Related]
55. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
[TBL] [Abstract][Full Text] [Related]
56. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
[TBL] [Abstract][Full Text] [Related]
57. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
58. Protein-mediated inward translocation of phospholipids occurs in both the apical and basolateral plasma membrane domains of epithelial cells.
Pomorski T; Herrmann A; Müller P; van Meer G; Burger K
Biochemistry; 1999 Jan; 38(1):142-50. PubMed ID: 9890892
[TBL] [Abstract][Full Text] [Related]
59. Nonlinear intestinal absorption of 5-hydroxytryptamine receptor antagonist caused by absorptive and secretory transporters.
Tamai I; Saheki A; Saitoh R; Sai Y; Yamada I; Tsuji A
J Pharmacol Exp Ther; 1997 Oct; 283(1):108-15. PubMed ID: 9336314
[TBL] [Abstract][Full Text] [Related]
60. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
